 Home > Food News > Nutrition News > Where the new generation of mRNA vaccines and therapies is headed has become a concern

Where the new generation of mRNA vaccines and therapies is headed has become a concern

 Last Update: 2022-09-14
 Source: Internet
 Author: User

Tags

fisher scientific pittsburgh

scientific poster size

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

After the great success of mRNA as a new treatment model in the field of COVID-19 vaccines, where the new generation of mRNA vaccines and therapies is going has also become a concern

The company's co-founders include Dr.

However, the wider use of further promotion of RNA therapies faces a number of obstacles

The immunogenicity of mRNA and delivery vectors remains a major challenge limiting their application

Orbital's goal is to bring together and integrate existing and emerging RNA technologies and delivery mechanisms to build a unique RNA technology platform

The company's LNP screening platform is able to discover LNP formulations that deliver RNA to different cells and tissues

▲Beam's LNP screening platform (Image source: Beam's official website)

In addition to providing technical support, Dr.

John Evans, CEO of Beam Therapeutics, shared how to navigate disruptive technologies at the WuXi AppTec Global Forum

Orbital's scientific founders include several pioneers in RNA research, including Professor Drew Weissman of the University of Pennsylvania who co-founded it with Dr.

Orbital's scientific founders included Professor Drew Weissman, a pioneer in RNA research, which was co-founded last year with Dr.

The innovative technology based on mRNA modifications they jointly discovered not only makes it possible to rapidly develop a COVID-19 vaccine, but is also being used to treat and prevent a range of other diseases

Professor Howard Chang of Stanford University is an expert in the field of long noncoding RNA (lnRNA), which plays an important role

"Biotechnology Company"

▲ The scientific founder of Orbital (Image source: Orbital official website)

Orbital's initial investments came from ARCH Venture Partners, a16z Bio + Health and Newpath Partners.

"Orbital, founded by visionary leaders and scientific pioneers, integrates a wide range of RNA technologies into one organization with the goal of developing entirely new drugs that have a profound impact on

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Factory Provide Citicoline Sodium CAS 33818-15-4 Cdp-Choline Sodium Citicoline Sodium

CAS No.: 33818-15-4

Pharmacy Grade

$100-101/KG FOB

Food Grade Anti Aging CAS 23111-00-4 99% Nicotinamide Riboside Chloride Nrc Nr-Cl Powder

CAS No.: 23111-00-4

Food Grade

$200-201/KG FOB

Cartilage extract

CAS No.:

$75-89/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.